AUPHAurinia Pharmaceuticals Inc.
$16.65+28% 1Y
$16.65
$11.0552 weeks$18.62
Is the price fair?
What AUPH's price assumes
Aurinia Pharmaceuticals Inc. trades at 7.27× earnings against 18.8× for the median Biotechnology name, cheaper than its own group.
7.27
Trailing P/E · Biotechnology median 18.8 · cheaper than the typical name in its group
- Price / sales
- 7.52
Price / sales · as of 2026-Q2
- Price / book
- 3.81
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 3.81
- Healthcare median P/E509 names
- 26.2
- Biotechnology median P/E244 names
- 18.8
- Market capitalisation
- $2.26B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.